Next-generation sequencing in schizophrenia and other neuropsychiatric disorders

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 7, 2013, Pages 671-678

  Schreiber, Matthew ^a,b   Dorschner, Michael ^a,b,c   Tsuang, Debby ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autism; Genetics; Schizophrenia; Sequencing; Whole exome

Indexed keywords

CHROMOSOME 5Q; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CYTOGENETICS; EXOME; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; INTELLECTUAL IMPAIRMENT; KARYOTYPING; MENTAL DISEASE; NEUROLOGIC DISEASE; NONSENSE MUTATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING;

AUTISM; GENETICS; SCHIZOPHRENIA; SEQUENCING; WHOLE EXOME;

GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INHERITANCE PATTERNS; MODELS, GENETIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84885767134     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32156     Document Type: Review

References (72)

1. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA, Consortium GP. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491(7422):56-65.
2. Avramopoulos D. 2010. Genetics of psychiatric disorders methods: molecular approaches. Clin Lab Med 30(4):815-827.
3. Awadalla P, Gauthier J, Myers RA, Casals F, Hamdan FF, Griffing AR, Côté M, Henrion E, Spiegelman D, Tarabeux J, et al. 2010. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 87(3):316-324.
4. Bassett AS, Hodgkinson K, Chow EW, Correia S, Scutt LE, Weksberg R. 1998. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 81(4):328-337.
5. Bassett AS, Chow EW, Weksberg R. 2000. Chromosomal abnormalities and schizophrenia. Am J Med Genet 97(1):45-51.
6. Bassett AS, Costain G, Fung WL, Russell KJ, Pierce L, Kapadia R, Carter RF, Chow EW, Forsythe PJ. 2010a. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J Psychiatr Res 44(15):1005-1009.
7. Bassett AS, Scherer SW, Brzustowicz LM. 2010b. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167(8):899-914.
8. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456(7218):53-59.
9. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, Roberts W, Szatmari P, Pinto D., et al., 2010. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42(6):489-491.
10. Biesecker LG, Burke W, Kohane I, Plon SE, Zimmern R. 2012. Next-generation sequencing in the clinic: Are we ready? Nat Rev Genet 13(11):818-824.
11. Bodmer W, Bonilla C. 2008. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40(6):695-701.
12. Bras J, Guerreiro R, Hardy J. 2012. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci 13(7):453-464.
13. Brown AS. 2006. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32(2):200-202.
14. Carroll LS, Owen MJ. 2009. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 1(10):102.
15. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, Hobbs HH. 2006. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proceedings of the National Academy of Sciences of the United States of America 103(6):1810-1815.
16. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, Idaghdour Y, Hartl CL, Torroja C, Garimella KV, et al. 2011. Variation in genome-wide mutation rates within and between human families. Nat Genet 43(7):712-714.
17. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C., et al. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367(20):1921-1929.
18. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, and others. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491-498.
19. Faraone SV, Tsuang MT, Tsuang DW. 1999. Genetics of mental disorders : A guide for students, clinicians, and researchers. New York: Guilford Press. xvi p. 272.
20. Gejman PV, Sanders AR, Kendler KS. 2011. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet 12:121-144.
21. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, et al. 2011. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 43(9):860-863.
22. Glatt SJ, Chandler SD, Bousman CA, Chana G, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Everall IP, et al. 2009. Alternatively spliced genes as biomarkers for schizophrenia, bipolar disorder and psychosis: A blood-based spliceome-profiling exploratory study. Curr Pharmacogenomics Person Med 7(3):164-188.
23. Goldstein DB, Chikhi L. 2002. Human migrations and population structure: What we know and why it matters. Annu Rev Genomics Hum Genet 3:129-152.
24. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. 2008. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 82(1):100-112.
25. Gottesman II, Wolfgram DL. 1991. Schizophrenia genesis : The origins of madness. New York: Freeman. xiii, p. 296.
26. Hirschhorn JN, Daly MJ. 2005. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6(2):95-108.
27. International Schizophrenia Consortium. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210):237-241.
28. Iyengar SK, Elston RC. 2007. The genetic basis of complex traits: Rare variants or "common gene, common disease"? Methods Mol Biol 376:71-84.
29. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92(17):7612-7616.
30. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, et al. 2008. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82(1):199-207.
31. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ. 2009. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35(5):851-854.
32. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, Moran J, Chambert K, Toncheva D, Georgieva L, et al. 2012. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17(2):142-153.
33. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Wong WS, et al. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488(7412):471-475.
34. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754-1760.
35. Li H, Ruan J, Durbin R. 2008. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18(11):1851-1858.
36. Marchani E, Chapman N, Cheung C, Ankenman K, Stanaway I, Coon H, Nickerson D, Bernier R, Brkanac Z, Wijsman E. In press. Identification of rare variants from exome sequence in a large pedigree with autism. Hum Hered.
37. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, and others. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297-1303.
38. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, St Clair DM, Muir WJ, Blackwood DH, et al. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9(9):1415-1423.
39. Müller N, Schwarz MJ. 2010. Immune system and schizophrenia. Curr Immunol Rev 6(3):213-220.
40. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10):940-945.
41. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, et al. 2012. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485(7397):242-245.
42. Need AC, McEvoy JP, Gennarelli M, Heinzen EL, Ge D, Maia JM, Shianna KV, He M, Cirulli ET, Gumbs CE, et al. 2012. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet 91(2):303-312.
43. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah X, et al. 2009a. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 14(8):774-785.
44. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, et al. 2009b. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461(7261):272-276.
45. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, et al. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43(6):585-589.
46. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. 2010. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466(7304):368-372.
47. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D. 1994. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182(8):476-478.
48. Reich DE, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet 17(9):502-510.
49. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, et al. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43(10):969-976.
50. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39(4):513-516.
51. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, Chu SH, Moreau MP, Gupta AR, Thomson SA, et al. 2011. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70(5):863-885.
52. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, et al. 2012. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485(7397):237-241.
53. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, et al. 2007. Strong association of de novo copy number mutations with autism. Science 316(5823):445-449.
54. Shendure J. 2011. Next-generation human genetics. Genome Biol 12(9):408.
55. Slater E, Tsuang MT. 1968. Abnormality on paternal and maternal sides: observations in schizophrenia and manic-depression. J Med Genet 5(3):197-199.
56. Smith DJ, Lusis AJ. 2002. The allelic structure of common disease. Hum Mol Genet 11(20):2455-2461.
57. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ. 1990. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336(8706):13-16.
58. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460(7256):744-747.
59. Sullivan PF, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M, Fruchter E, Hultman CM, Lundberg M, Långström N, et al. 2012. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry 69(11):1099-1110.
60. Tam GW, Redon R, Carter NP, Grant SG. 2009. The role of DNA copy number variation in schizophrenia. Biol Psychiatry 66(11):1005-1012.
61. Timms AE, Dorschner MO, Wechsler J, Choi KY, Kirkwood R, Girirajan S, Baker C, Eichler EE, Korvatska O, Roche KW, et al. In press. Support for the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry.
62. Tsuang MT. 1993. Genotypes, phenotypes, and the brain. A search for connections in schizophrenia. Br J Psychiatry 163:299-307.
63. Tsuang MT. 1994. Genetics, epidemiology, and the search for causes of schizophrenia. Am J Psychiatry 151(1):3-6.
64. Tsuang MT, Faraone SV. 1995. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 17(2):161-175.
65. Tsuang MT, Fowler RC, Cadoret RJ, Monnelly E. 1974. Schizophrenia among first-degree relatives of paranoid and nonparanoid schizophrenics. Compr Psychiatry 15(4):295-302.
66. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, et al. 2010. A de novo paradigm for mental retardation. Nat Genet 42(12):1109-1112.
67. Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. the Autism Genome Project ISC. 2012. No evidence that common genetic risk variation is shared between schizophrenia and autism. Am J Med Genet B 162(1):55-60.
68. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539-543.
69. Wijsman EM. 2012. The role of large pedigrees in an era of high-throughput sequencing. Hum Genet 131(10):1555-1563.
70. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. 2008. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40(7):880-885.
71. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M. 2011. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 43(9):864-868.
72. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA, Karayiorgou M. 2012. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 44(12):1365-1369.